Hemifacial spasm and reinnervation synkinesias: Long-term treatment with either Botox® or Dysport®

Journal of Neural Transmission

Volumn 117, Issue 6, 2010, Pages 759-763

  Kollewe, Katja ^a   Mohammadi, Bahram ^a   Dengler, Reinhard ^a   Dressler, Dirk ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Botox ; Botulinum toxin; Conversion factor; Dysport ; Hemifacial spasm; Reinnervation sykinesias

Indexed keywords

BOTULINUM TOXIN A;

ADULT; AGED; ARTICLE; DIPLOPIA; DRUG EFFICACY; DRY EYE; FACE WEAK; FACE WEAKNESS; FEMALE; HEMIFACIAL SPASM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PTOSIS; REINNERVATION; SYNKINESIS; THERAPY EFFECT; TREATMENT DURATION; TREATMENT FAILURE; UNSPECIFIED SIDE EFFECT; WEAKNESS;

ADULT; AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; HEMIFACIAL SPASM; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; REACTION TIME; SYNKINESIS; TIME FACTORS;

EID: 77954541216     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-010-0409-4     Document Type: Article

References (55)

1. CH Adler RA Zimmerman PJ Savino B Bernardi TM Bosley RC Sergott 1992 Hemifacial spasm: evaluation by magnetic resonance imaging and magnetic resonance tomographic angiography Ann Neurol 32 4 502 506 10.1002/ana.410320404 1:STN:280:DyaK3s%2FovFyrsg%3D%3D 1456734
2. JR Ainsworth SP Kraft 1995 Long-term changes in duration of relief with botulinum toxin treatment of essential blepharospasm and hemifacial spasm Ophthalmology 102 12 2036 2040 1:STN:280:DyaK2s3lt1ymtA%3D%3D 9098314
3. RS Baker MW Stava KR Nelson PJ May MD Huffman JD Porter 1994 Aberrant reinnervation of facial musculature in a subhuman primate: a correlative analysis of eyelid kinematics, muscle synkinesis, and motoneuron localization Neurology 44 11 2165 2173 1:STN:280:DyaK2M%2FmtVSisg%3D%3D 7969978
4. AR Bentivoglio A Fasano T Ialongo F Soleti S Lo Fermo A Albanese 2009 Outcome predictors, efficacy and safety of Botox and Dysport in the long-term treatment of hemifacial spasm Eur J Neurol 16 3 392 398 10.1111/j.1468-1331. 2008.02507.x 1:STN:280:DC%2BD1M3nsFCnsQ%3D%3D 19364366
5. DC Bills A Hanieh 1991 Hemifacial spasm in an infant due to fourth ventricular ganglioglioma. Case report J Neurosurg 75 1 134 137 10.3171/jns.1991.75.1.0134 1:STN:280:DyaK3M3lvFagsg%3D%3D 2045898
6. MF Brin A Blitzer 1993 Botulinum toxin: dangerous terminology errors J R Soc Med 86 8 493 494 1:STN:280:DyaK2czlvVyktA%3D%3D 8078064
7. HJ Chen TC Lee CC Lui 1996 Hemifacial spasm caused by a venous angioma. Case report J Neurosurg 85 4 716 717 10.3171/jns.1996.85.4.0716 1:STN:280:DyaK28vgvFajsw%3D%3D 8814183
8. C Colosimo M Bologna S Lamberti L Avanzino L Marinelli G Fabbrini G Abbruzzese G Defazio A Berardelli 2006 A comparative study of primary and secondary hemifacial spasm Arch Neurol 63 3 441 444 10.1001/archneur.63.3.441 16533973
9. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005) Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev 2005(1):CD004899
10. G Defazio G Abbruzzese P Girlanda L Vacca A Curra R De Salvia R Marchese R Raineri F Roselli P Livrea A Berardelli 2002 Botulinum toxin A treatment for primary hemifacial spasm: a 10-year multicenter study Arch Neurol 59 3 418 420 10.1001/archneur.59.3.418 11890846
11. K Digre JJ Corbett 1988 Hemifacial spasm: differential diagnosis, mechanism, and treatment Adv Neurol 49 151 176 1:STN:280:DyaL1c7kslGrsQ%3D%3D 3278539
12. JS Elston 1992 The management of blepharospasm and hemifacial spasm J Neurol 239 1 5 8 10.1007/BF00839203 1:STN:280:DyaK387ns12ksg%3D%3D 1541971
13. M Flanders D Chin D Boghen 1993 Botulinum toxin: preferred treatment for hemifacial spasm Eur Neurol 33 4 316 319 10.1159/000116961 1:STN:280: DyaK3szltFKjsA%3D%3D 8348919
14. N Galvez-Jimenez MR Hanson M Desai 2001 Unusual causes of hemifacial spasm Sem Neurol 21 1 75 83 10.1055/s-2001-13122 1:STN:280: DC%2BD3M3ltVWmsQ%3D%3D
15. N Girard M Poncet F Caces Y Tallon A Chays P Martin-Bouyer J Magnan C Raybaud 1997 Three-dimensional MRI of hemifacial spasm with surgical correlation Neuroradiology 39 1 46 51 10.1007/s002340050366 1:STN:280:DyaK2s7otFCjtw%3D%3D 9121649 (Pubitemid 27037807)
16. LF Gomez-Perals M Ortega-Martinez I Fernandez-Portales JM Cabezudo-Artero 2005 Hemifacial spasm as clinical presentation of intracranial meningiomas. Report of three cases and review of the literature Neurocirugia (Astur) 16 1 21 25 1:STN:280:DC%2BD2M7js1Onsw%3D%3D discussion 26
17. P Hambleton AM Pickett 1994 Potency equivalence of botulinum toxin preparations J R Soc Med 87 11 719 1:STN:280:DyaK2M7jvV2qtQ%3D%3D 7837204
18. GY Hsiung SK Das R Ranawaya AL Lafontaine O Suchowersky 2002 Long-term efficacy of botulinum toxin A in treatment of various movement disorders over a 10-year period Mov Disord 17 6 1288 1293 10.1002/mds.10252 12465070 (Pubitemid 36041344)
19. J Jankovic K Schwartz 1995 Response and immunoresistance to botulinum toxin injections Neurology 45 9 1743 1746 1:STN:280:DyaK2MvgsFKgug%3D%3D 7675238
20. S Jitpimolmard S Tiamkao M Laopaiboon 1998 Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases J Neurol Neurosurg Psychiatry 64 6 751 757 10.1136/jnnp.64.6.751 1:STN:280:DyaK1czgvFGiuw%3D%3D 9647304
21. C Kenney J Jankovic 2008 Botulinum toxin in the treatment of blepharospasm and hemifacial spasm J Neural Transm 115 4 585 591 10.1007/s00702-007-0768-7 1:CAS:528:DC%2BD1cXksFygsL4%3D 17558461 (Pubitemid 351534034)
22. H Kobata A Kondo K Iwasaki T Nishioka 1998 Combined hyperactive dysfunction syndrome of the cranial nerves: trigeminal neuralgia, hemifacial spasm, and glossopharyngeal neuralgia: 11-year experience and review Neurosurgery 43 6 1351 1361 10.1097/00006123-199812000-00052 1:STN:280:DyaK1M%2FmtlGqtw%3D%3D 9848849 discussion 1361-1352
23. SP Kraft AE Lang 1988 Botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, and eyelid fasciculations Can J Neurol Sci 15 3 276 280 1:STN:280:DyaL1M%2FovFCjsw%3D%3D 3208210
24. G Kranz D Haubenberger B Voller M Posch P Schnider E Auff T Sycha 2009 Respective potencies of Botox and Dysport in a human skin model: a randomized, double-blind study Mov Disord 24 2 231 236 10.1002/mds.22336 18951439
25. A Marchetti R Magar L Findley JP Larsen Z Pirtosek E Ruzicka R Jech J Slawek F Ahmed 2005 Retrospective evaluation of the dose of Dysport and BOTOX in the management of cervical dystonia and blepharospasm: the REAL DOSE study Mov Disord 20 8 937 944 10.1002/mds.20468 15810022 (Pubitemid 41419507)
26. K Matsumoto S Kimura K Kakita 2005 Endovascular treatment of vertebral artery aneurysm manifesting as progressive hemifacial spasm Neurologia Medico-Chirurgica 45 7 360 362 10.2176/nmc.45.360 16041182 (Pubitemid 41301702)
27. JA Mauriello Jr T Leone S Dhillon B Pakeman R Mostafavi MC Yepez 1996 Treatment choices of 119 patients with hemifacial spasm over 11 years Clin Neurol Neurosurg 98 3 213 216 10.1016/0303-8467(96)00025-X 8884091 (Pubitemid 26319402)
28. MR McLaughlin PJ Jannetta BL Clyde BR Subach CH Comey DK Resnick 1999 Microvascular decompression of cranial nerves: lessons learned after 4400 operations J Neurosurg 90 1 1 8 10.3171/jns.1999.90.1.0001 1:STN:280: DyaK1MzjvFCqtg%3D%3D 10413149
29. NI Mejia KD Vuong J Jankovic 2005 Long-term botulinum toxin efficacy, safety, and immunogenicity Mov Disord 20 5 592 597 10.1002/mds.20376 15645481 (Pubitemid 40862257)
30. Mohammadi B, Buhr N, Bigalke H, Krampfl K, Dengler R, Kollewe K (2009a) A long-term follow-up of botulinum toxin A in cervical dystonia. Neurol Res 31(5):463-466
31. B Mohammadi K Kollewe M Wegener H Bigalke R Dengler 2009 Experience with long-term treatment with albumin-supplemented botulinum toxin type A J Neural Transm 116 4 437 441 10.1007/s00702-009-0200-6 1:CAS:528:DC%2BD1MXks1Sisb8%3D 19319477
32. S Nagata K Fujii T Nomura T Matsushima M Fukui K Yasumori 1991 Hemifacial spasm caused by CP angle AVM associated with ruptured aneurysm in the feeding artery-case report Neurologia Medico-Chirurgica 31 7 406 409 10.2176/nmc.31.406 1:STN:280:DyaK38%2Fms1Whsw%3D%3D 1720219
33. S Nagata T Matsushima K Fujii M Fukui C Kuromatsu 1992 Hemifacial spasm due to tumor, aneurysm, or arteriovenous malformation Surg Neurol 38 3 204 209 10.1016/0090-3019(92)90170-R 1:STN:280:DyaK3s%2FmvVOmtA%3D%3D 1440205
34. JS Neimat BL Hoh MJ McKenna JD Rabinov CS Ogilvy 2005 Aneurysmal expansion presenting as facial weakness: case report and review of the literature Neurosurgery 56 1 190 15617605
35. P Papanagiotou IQ Grunwald M Politi T Struffert F Ahlhelm W Reith 2006 Vascular anomalies of the cerebellopontine angle Der Radiologe 46 3 216 222 10.1007/s00117-005-1327-6 1:STN:280:DC%2BD287mtVyrsQ%3D%3D 16432753
36. YC Park JK Lim DK Lee SD Yi 1993 Botulinum a toxin treatment of hemifacial spasm and blepharospasm J Korean Med Sci 8 5 334 340 1:STN:280:DyaK2c7jslersg%3D%3D 8305141
37. AM Pickett P Hambleton 1994 Dose standardisation of botulinum toxin Lancet 344 8920 474 475 10.1016/S0140-6736(94)91806-6 1:STN:280: DyaK2czjsFChtg%3D%3D 7914582
38. N Platania GF Nicoletti G Barbagallo V Albanese 1997 Concurrent trigeminal and glossopharyngeal neuralgia, hemifacial spasm and hypertension by neurovascular compression. Case report J Neurosurg Sci 41 3 303 307 1:STN:280:DyaK1c7gs12qsg%3D%3D 9444585
39. N Poungvarin A Viriyavejakul 1992 Two hundred and fifty patients with hemifacial spasm treated with botulinum toxin injection J Med Assoc Thai 75 4 199 203 1:STN:280:DyaK3s%2FhvVGktA%3D%3D 1402442
40. D Ranoux C Gury J Fondarai JL Mas M Zuber 2002 Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia J Neurol Neurosurg Psychiatry 72 4 459 462 1:STN:280: DC%2BD387nslejsQ%3D%3D 11909903
41. A Rapana F Guida C Conti G Rizzo G Trincia 1999 Ependymoma of the fourth ventricle presenting with hemifacial spasm. Report of a case Revue Neurologique 155 4 309 311 1:STN:280:DyaK1M3psFCjtw%3D%3D 10367329
42. BA Rhee TS Kim GK Kim WL Leem 1995 Hemifacial spasm caused by contralateral cerebellopontine angle meningioma: case report Neurosurgery 36 2 393 395 10.1227/00006123-199502000-00021 1:STN:280:DyaK2M3kvFSktg%3D%3D 7731520
43. JD Rollnik M Matzke K Wohlfarth R Dengler H Bigalke 2000 Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study Eur Neurol 43 1 9 12 10.1159/000008121 1:CAS:528:DC%2BD3cXpt1aquw%3D%3D 10601802
44. B Sade G Mohr JJ Dufour 2005 Cerebellopontine angle lipoma presenting with hemifacial spasm: case report and review of the literature J Otolaryngol 34 4 270 273 10.2310/7070.2005.34416 16048703
45. C Sampaio JJ Ferreira F Simoes MJ Rosas M Magalhaes AP Correia A Bastos-Lima R Martins A Castro-Caldas 1997 DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A-Dysport and Botox-assuming a ratio of 4:1 Mov Disord 12 6 1013 1018 10.1002/mds. 870120627 1:STN:280:DyaK1c%2FmtFKhtQ%3D%3D 9399229 (Pubitemid 27496782)
46. DI Sandberg MM Souweidane 1999 Hemifacial spasm caused by a pilocytic astrocytoma of the fourth ventricle Pediatr Neurol 21 4 754 756 10.1016/S0887-8994(99)00077-6 1:STN:280:DC%2BD3c%2Fks1ymuw%3D%3D 10580892 (Pubitemid 29505346)
47. C Sprik JD Wirtschafter 1988 Hemifacial spasm due to intracranial tumor. An international survey of botulinum toxin investigators Ophthalmology 95 8 1042 1045 1:STN:280:DyaL1M7lvF2ntw%3D%3D 3266003
48. EK Tan LL Chan SH Lim WE Lim JB Khoo KP Tan 1999 Role of magnetic resonance imaging and magnetic resonance angiography in patients with hemifacial spasm Ann Acad Med Singap 28 2 169 173 1:STN:280:DyaK1Mvisleisg%3D%3D 10497660
49. JD Taylor SP Kraft MS Kazdan M Flanders W Cadera RB Orton 1991 Treatment of blepharospasm and hemifacial spasm with botulinum A toxin: a Canadian multicentre study Can J Ophthalmol 26 3 133 138 1:STN:280:DyaK3M3nsFSiuw%3D%3D 2054723
50. L Thomander 1984 Reorganization of the facial motor nucleus after peripheral nerve regeneration. An HRP study in the rat Acta Otolaryngol 97 5-6 619 626 10.3109/00016488409132939 1:STN:280:DyaL2c3ns1yltA%3D%3D 6464712
51. M Uchino J Nomoto T Ohtsuka T Kuramitsu 2005 Fusiform aneurysm of the vertebral artery presenting with hemifacial spasm treated by microvascular decompression Acta Neurochir 147 8 901 903 10.1007/s00701-005-0553-z 1:STN:280:DC%2BD2MzovFOnsw%3D%3D (Pubitemid 41103975)
52. T Vogt F Lussi A Paul P Urban 2008 Long-term therapy of focal dystonia and facial hemispasm with botulinum toxin A Der Nervenarzt 79 8 912 917 10.1007/s00115-008-2486-2 1:STN:280:DC%2BD1cvpvVyntA%3D%3D 18551268
53. A Wang J Jankovic 1998 Hemifacial spasm: clinical findings and treatment Muscle Nerve 21 12 1740 1747 10.1002/(SICI)1097-4598(199812)21:12<1740::AID- MUS17>3.0.CO;2-V 1:STN:280:DyaK1M%2Flslaisw%3D%3D 9843077 (Pubitemid 28545706)
54. K Wohlfarth T Sycha D Ranoux H Naver D Caird 2009 Dose equivalence of two commercial preparations of botulinum neurotoxin type A: time for a reassessment? Curr Med Res Opin 25 7 1573 1584 10.1185/03007990903028203 1:CAS:528:DC%2BD1MXnsFKqsbs%3D 19463043
55. DM Yoshimura MJ Aminoff TA Tami AB Scott 1992 Treatment of hemifacial spasm with botulinum toxin Muscle Nerve 15 9 1045 1049 10.1002/mus.880150909 1:STN:280:DyaK38zovF2ksg%3D%3D 1518513